INDIA: BioAsia – the marquee healthcare and Life Sciences event, organized by the Government of Telangana, is all set for the grand unveiling of its 21^st edition in Hyderabad. Sri Duddilla Sridhar Babu, Minister for Information Technology, Industries & Commerce conducted a comprehensive review of the preparations for the upcoming global conference. As the Flagship event of the Government of Telangana, BioAsia has emerged as a pivotal player in steering the life-sciences development journey in India, playing a crucial role in redirecting focus towards the advancements and challenges within the industry. The event is scheduled to be held between February 26 and 28, 2024 at the Hyderabad International Convention Center (HICC) in Hyderabad.

Distinctly, the 21st edition of BioAsia will feature prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, and will explore the theme of  Data & AI: Redefining Possibilities, to deliberate the possibility of reshaping the future of health tech delivery paradigm in the country. The event boasts a lineup of 70+ influential speakers, including global CEOs and industry leaders. Besides, the Keynote speakers already announced for the event including Mr. David Ricks (CEO, Eli Lilly, and Company), Dr. Christopher Boerner (Incoming CEO, Bristol Myers Squibb), Mr. Geoff Martha (Chairman and CEO, Medtronic), Prof. Gregg Semenza (Nobel Laureate & Professor at Johns Hopkins School of Medicine), among others, the event will also feature President and CEO, Olympus Mr. Stefan Kaufmann; CEO of Providence Dr. Rod Hochman, M.D., Global Operating Partner of Advent International Mr. Stefan Stoffel, among others.

With expectations soaring high with an extraordinary line-up of speakers, BioAsia 2024 is projected to attract over 3000 participants, offering a dynamic platform for networking and collaboration. Further, the event will have an increased exhibition this year with more than 200 companies set to showcase some of the most groundbreaking advancements and cutting-edge products. As the city welcomes numerous globally influential leaders, the event will provide a fertile ground for knowledge exchange and innovation in the life sciences and biotechnology sector. BioAsia 2024 will also offer a worldwide platform for promising startups in the pharmaceutical, biotech, life sciences, health-tech, and med-tech sectors to showcase their inventive concepts.

Sridhar Babu, Hon Minister for Industries & Commerce Dept., Government of Telangana, expressed his enthusiasm for the event’s growing global stature. He stated, “BioAsia has emerged as a critical instrument for the development of the Indian and global life science and allied industries over the last two decades. We are thrilled to announce that several global CEOs will be attending BioAsia for the first time, underlining the event’s rising prominence on the international stage. My team and I are leaving no stone unturned to ensure that BioAsia 2024 is grand and impactful. It’s not just an event; it’s a culmination of two decades of excellence. Together, let’s shape the future of healthcare”

Jayesh Ranjan, IAS, Principal Secretary, Industries & Commerce Dept., Government of Telangana, expressed his enthusiasm for the event’s growing global stature. He said, “Over the past 20 editions, BioAsia has played an unmatched role in sparking the renewed emphasis on the life-sciences industry, rekindling attention from regulation, corporates, startups, and allied sectors alike. “

“The 21st edition of BioAsia is certainly going to be a milestone event, as the presence of global leaders marks the vision to bridge the gaps in the healthcare industry and foster innovation in these critical sectors,” said Shakthi Nagappan, Director of Life Sciences, Govt. of Telangana and CEO of BioAsia.

The event, with EY as the knowledge partner, will focus on themes including Transformative innovation – R&D, Patent Paradox: India’s Bid for Global R&D Dominance & IP Dilemmas, Leading the Health-tech revolution – The Next Normal, India at the frontier of Pharma Services, MedTech is the place to be, etc. that are pertinent to the industry in the current times.  

The post BioAsia 2024 set to host 3000+ Delegates from 50 Countries: Data and AI to Command Center Stage in the 21st Edition appeared first on NRI News.

Other speakers at the conference included Dr. Ashish Lele, Director of NCL, Dr. Pramod Chaudhari, Founder Chairman of Praj Industries, and Royal Society Fellow and Senior Scientist Dr. Raghunath Mashelkar. They discussed the social, environmental, and energy aspects of the bioeconomy and the need for a holistic and all-inclusive approach to accelerate its growth. Dr. Mashelkar emphasized the importance of policy and technology going hand in hand, while Dr. Chaudhari called for judicious use of genetically modified crops to maximize yields and productivity while conserving the environment.

Dr. Ashish Lele highlighted the need to move away from the traditional practice of stubble burning and instead utilize biomass for the production of biofuels and renewable chemicals and materials on a waste-to-wealth principle. He also praised Pune’s facilities for research and development in bioeconomy and its thriving ecosystem for start-ups.

The conference also featured a panel discussion on the importance of biomanufacturing in building a bio-economy, with Dr. Asha Kembhavi, Bio Technologist, and Dr. Prashant Dhakefalkar, Director of Agharkar Research Institute, participating.

This conference highlighted India’s potential to become a global leader in bioeconomy and the need for a collaborative approach to harness its resources and technologies for sustainable development.

The post India Poised to Lead in Bioeconomy with Global Biofuels Alliance, Says Jim Lane at NCL Conference appeared first on NRI News.

The Nanotechnology Center is the sixth R&D facility of Coromandel and the second Tech Centre that will focus on the development of next-generation agri-inputs, the first being Coromandel’s research facility in Monash Academy, IIT Bombay. The center will facilitate the wider application of nano-inputs in agriculture by disseminating scientific data and knowledge to farmers, scientists, and policymakers. It will also serve as the central laboratory for all nano-products of Coromandel to ensure full compliance with regulatory guidelines and develop a wide range of bioproducts.

Earlier this year, the company launched Nano DAP, which has received an encouraging response from the farming community. Recently, it has also developed a unique Nano Urea formulation containing 12% N (w/w), which is undergoing extensive farmer trials. The company is in the process of setting up an integrated Nano products manufacturing facility at Kakinada.

Speaking on the occasion, Coromandel’s Executive Vice Chairman Mr. Arun Alagappan said, “The Coromandel Nanotechnology Center is a unique facility established to drive Coromandel’s efforts in nanotechnology in agriculture. This will enable high-quality research in the nano space and is in line with various Government initiatives to promote innovation and the use of technology. This is a major step towards strengthening India’s R&D capabilities for the development of efficient plant nutrition and protection solutions.“

Coromandel International Limited is amongst India’s pioneers and leading agri solutions provider, offering diverse products and services across the farming value chain. The company operates in two major segments: Nutrient and other allied businesses and Crop Protection. These include Fertilizer, Crop Protection, Bio Products, Specialty Nutrients, and Organic businesses. The company is the second-largest manufacturer and marketer of Phosphatic fertilizer in India. The company’s Crop Protection products are marketed in India as well as in international geographies, offering a wide range of technical and formulation products. The Specialty Nutrients business of the company focuses on water-soluble fertilizers and secondary & micronutrients segments. The company is a leading marketer of Organic fertilizer in India. The Bio Products business of the company focuses on plant extractions for various applications. It also operates a network of around 750+ rural retail outlets across Andhra Pradesh, Telangana, and Karnataka. Through these retail outlets, the company offers farming services, including crop advisory, soil testing, and farm mechanization, to around 3 million farmers. The company has a strong R&D and Regulatory setup, supporting the businesses in process development and new product introduction. The company has 18 manufacturing facilities, producing a wide range of Nutrient and Crop Protection products, which are marketed through an extensive network of dealers and its retail centers.

The company clocked a turnover of Rs.29,799 Crores during FY22-23. Its efforts towards the environment have been well recognized by international organizations like UNDP and have also been voted as one of the ten greenest companies in India by TERI. Coromandel is a part of the INR 742 billion (INR 74,220 Crores) of the Murugappa Group.

The post Coromandel Unveils Nanotechnology Center to Drive Nano Solutions in Agriculture appeared first on NRI News.